Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorNom chimique: N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(2,3-bis(palmitoyloxy)propyl)-L-cysteine // Synonymes: (2R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((2,3-bis(palmitoyloxy)propyl)thio)propanoic acid, Fmoc-Cys(glycyl-bis-palmityl)-OH,1,1'-[1-[[[(2R)-2-Carboxy-2-[[(9H-fluoren-9-ylmethoxy)carbony l]amino]ethyl]thio]methyl]-1,2-ethanediyl] dihexad
from Sur demande
Fully synthetic self-adjuvanting MUC1-fibroblast stimulating lipopeptide 1 conjugates as potential cancer vaccines. Liu Y., Zhang W., He Q., Yu F., Song T., Liu T., Zhang Z., Zhou J., Wang P.G., Zhao W.; Chem. Comm. 2016; 52(72): 10886-10889. DOI: 10.1039/c6cc04623a
N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2. Willems M.M., Zom G.G., Khan S., Meeuwenoord N., Melief C.J., van der Stelt M., Overkleeft H.S., Codée J.D., van der Marel G.A., Ossendorp F., Filippov D.V.; J. Med. Chem. 2014; 57(15): 6873-8. DOI: 10.1021/jm500722p.
Novel Toll-like Receptor 2 Ligands for Targeted Pancreatic Cancer Imaging and Immunotherapy. Amanda Shanks Huynh, Woo Jin Chung, Hyun-Il Cho, Valerie E. Moberg, Esteban Celis, David L. Morse, Josef Vagner; J. Med. Chem. 2012; 55(22): 9751-9762. DOI: 10.1021/jm301002f
Engineered Synthetic Virus-Like Particles and Their Use in Vaccine Delivery. Arin Ghasparian, Tina Riedel, Jimy Koomullil, Kerstin Moehle, Christian Gorba, Dmitri I. Svergun, Adam W. Perriman, Stephen Mann, Marco Tamborrini, Gerd Pluschke, John A. Robinson; ChemBioChem 2011; 12(1): 100-109. DOI: 10.1002/cbic.201000536
Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen. Buskas T., Ingale S., Boons G.J.; Angew Chem Int Ed Engl. 2005; 44(37): 5985-5988. DOI: 10.1002/anie.200501818
Stereochemical Dependence of the Self-Assembly of the Immunoadjuvants Pam3Cys and Pam3Cys-Ser. Frank Reichel, Annie M. Roelofsen, Hubertus P. M. Geurts, Taina I. Hämäläinen, Martinus C. Feiters, Geert-Jan Boons; J. Am. Chem. Soc. 1999; 121(35): 7989-7997. DOI: 10.1021/ja991319q
International Journal of Peptide and Protein Research
Synthesis of Ná‐Fmoc protected derivatives of S‐(2,3‐dihydroxypropyl)‐cysteine and their application in peptide synthesis. Jörg W. Metzger, Karl-Heinz Wiesmüller, Günther Jung; Int. J. Peptide Res. 1991; 38(6): 545-554. DOI: 10.1111/j.1399-3011.1991.tb01538.x
Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes comparison of the costimulating support provided by helper T cells and lipoamino acid. Eric Borgesa, Karl-Heinz Wiesmüller, Günther Jung, Peter Walden; Journal of Immunological Methods 1994; 173(2): 253-263. DOI: 10.1016/0022-1759(94)90304-2